March 24, 2020 / 7:08 AM / 6 days ago

BRIEF-Herantis Pharma Says Covid-19 May Require Rescheduling Of Planned Treatments

March 24 (Reuters) - Herantis Pharma Oyj:

* HERANTIS PHARMA PLC ANNOUNCES CAPITAL MARKETS DAY WEBCAST AND PROVIDES UPDATE ON BUSINESS OPERATIONS DURING COVID-19

* ON CORONAVIRUS: UPDATE ON ITS BUSINESS OPERATIONS DURING COVID-19 (CORONAVIRUS) PANDEMIC.

* COVID-19 OUTBREAK MAY REQUIRE RESCHEDULING OF SOME OF PLANNED TREATMENTS, COMPANY DOES NOT ANTICIPATE THAT SUCH CHANGES WILL HAVE ANY MATERIAL IMPACT ON OUTCOMES OF THESE CLINICAL TRIALS.

* DOES NOT CURRENTLY FORESEE ESSENTIAL IMPACT ON ITS PLANS, AND COMPANY’S PREVIOUSLY COMMUNICATED OUTLOOK FOR 2020 AND GUIDANCE FOR 2020 REMAIN UNCHANGED Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below